GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Easywell Biomedicals Inc (ROCO:1799) » Definitions » Gross Profit

Easywell Biomedicals (ROCO:1799) Gross Profit : NT$196.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Easywell Biomedicals Gross Profit?

Easywell Biomedicals's gross profit for the three months ended in Mar. 2024 was NT$43.7 Mil. Easywell Biomedicals's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was NT$196.8 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Easywell Biomedicals's gross profit for the three months ended in Mar. 2024 was NT$43.7 Mil. Easywell Biomedicals's Revenue for the three months ended in Mar. 2024 was NT$73.4 Mil. Therefore, Easywell Biomedicals's Gross Margin % for the quarter that ended in Mar. 2024 was 59.48%.

Easywell Biomedicals had a gross margin of 59.48% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Easywell Biomedicals was 63.87%. The lowest was 3.53%. And the median was 10.97%.


Easywell Biomedicals Gross Profit Historical Data

The historical data trend for Easywell Biomedicals's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easywell Biomedicals Gross Profit Chart

Easywell Biomedicals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.46 83.96 50.43 76.31 170.72

Easywell Biomedicals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.61 42.63 47.00 63.48 43.67

Competitive Comparison of Easywell Biomedicals's Gross Profit

For the Medical Devices subindustry, Easywell Biomedicals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easywell Biomedicals's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Easywell Biomedicals's Gross Profit distribution charts can be found below:

* The bar in red indicates where Easywell Biomedicals's Gross Profit falls into.



Easywell Biomedicals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Easywell Biomedicals's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=271.628 - 100.91
=170.7

Easywell Biomedicals's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=73.418 - 29.748
=43.7

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$196.8 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Easywell Biomedicals's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=43.7 / 73.418
=59.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Easywell Biomedicals  (ROCO:1799) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Easywell Biomedicals had a gross margin of 59.48% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Easywell Biomedicals Gross Profit Related Terms

Thank you for viewing the detailed overview of Easywell Biomedicals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Easywell Biomedicals (ROCO:1799) Business Description

Traded in Other Exchanges
N/A
Address
No.10, Yanfa 2nd Rd, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076
Easywell Biomedicals Inc is engaged in the design, manufacture, and sales of thermometers for measuring body temperature and other medical instruments such as digital clinical thermometers, infrared ear thermometers, probe covers, and blood/urine/total cholesterol metabolites monitoring systems, among others. It has a Drug development segment and Other segments.

Easywell Biomedicals (ROCO:1799) Headlines

No Headlines